Mostrar el registro sencillo del ítem
dc.contributor.author | Fletcher, Katherine | es_ES |
dc.contributor.author | Shah, Rashmi R. | es_ES |
dc.contributor.author | Thomas, Arthur | es_ES |
dc.contributor.author | Tobin, Frank | es_ES |
dc.contributor.author | Rodríguez, Blanca | es_ES |
dc.contributor.author | Mirams, Gary R. | es_ES |
dc.contributor.author | Saiz Rodríguez, Francisco Javier | es_ES |
dc.contributor.author | Noble, Denis | es_ES |
dc.date.accessioned | 2015-06-01T07:37:31Z | |
dc.date.issued | 2011 | |
dc.identifier.issn | 0114-5916 | |
dc.identifier.uri | http://hdl.handle.net/10251/51028 | |
dc.description.sponsorship | This work was supported in part by the European Union (EU)-funded FP6-project ePIXnet, and in part by the FP7-project BOOM. | |
dc.language | Inglés | es_ES |
dc.publisher | Springer Verlag | es_ES |
dc.relation.ispartof | Drug Safety | es_ES |
dc.rights | Reserva de todos los derechos | es_ES |
dc.subject | Silico Cardiac Modelling | es_ES |
dc.subject | Regulators | es_ES |
dc.subject | Proarrhythmic Safety of Drugs | es_ES |
dc.subject.classification | TECNOLOGIA ELECTRONICA | es_ES |
dc.title | Novel approaches to assessing cardiac safety-proceedings of a workshop : Regulators, Industry and Academia Discuss the Future of In Silico Cardiac Modelling to Predict the Proarrhythmic Safety of Drugs | es_ES |
dc.type | Artículo | es_ES |
dc.embargo.lift | 10000-01-01 | |
dc.embargo.terms | forever | es_ES |
dc.identifier.doi | 10.2165/11591950-000000000-00000 | |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP7/224381/EU/Computational Prediction of Drug Cardiac Toxicity/ | es_ES |
dc.rights.accessRights | Cerrado | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Departamento de Ingeniería Electrónica - Departament d'Enginyeria Electrònica | es_ES |
dc.description.bibliographicCitation | Fletcher, K.; Shah, RR.; Thomas, A.; Tobin, F.; Rodríguez, B.; Mirams, GR.; Saiz Rodríguez, FJ.... (2011). Novel approaches to assessing cardiac safety-proceedings of a workshop : Regulators, Industry and Academia Discuss the Future of In Silico Cardiac Modelling to Predict the Proarrhythmic Safety of Drugs. Drug Safety. 34(5):439-443. https://doi.org/10.2165/11591950-000000000-00000 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.2165/11591950-000000000-00000 | es_ES |
dc.description.upvformatpinicio | 439 | es_ES |
dc.description.upvformatpfin | 443 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 34 | es_ES |
dc.description.issue | 5 | es_ES |
dc.relation.senia | 218789 | |
dc.identifier.eissn | 1179-1942 | |
dc.identifier.pmid | 21513366 | en_EN |
dc.identifier.pmcid | PMC3586146 | en_EN |
dc.contributor.funder | European Commission | |
dc.description.references | Rodriguez, B., Burrage, K., Gavaghan, D., Grau, V., Kohl, P., & Noble, D. (2010). The Systems Biology Approach to Drug Development: Application to Toxicity Assessment of Cardiac Drugs. Clinical Pharmacology & Therapeutics, 88(1), 130-134. doi:10.1038/clpt.2010.95 | es_ES |